“karyopharm-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More 07/05/19 National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
FDA Staff Hammers Karyopharm Cancer Drug on Safety, Efficacy Concerns 02/22/19 Boston
ASH 2018: Three Up, Two Down as Big Blood Disease Meeting Rolls On 12/03/18 National
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Keeping Focus on Cancer, Karyopharm Licenses Antiviral to Anivive 05/04/17 Boston
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat 06/06/14 Boston
East Coast Biotech Roundup: Arno, Accelerate LI, Immunogen, & More 11/08/13 Boston
Karyopharm Prices Upsized IPO at $16 Per Share, Begins Trading Today 11/06/13 Boston
Karyopharm Enters IPO Queue, Plots up to $80M Raise For Cancer Drug 10/07/13 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
East Coast Life Sciences Roundup: Regeneron, Actavis, NPS, & More 05/24/13 Boston
Karyopharm Grabs $48.2M Series B to Advance Cancer Drugs 05/20/13 Boston
Karyopharm Therapeutics Secures $48,200,000 Series B Round 05/20/13 Boston
Karyopharm Therapeutics Secures $20,500,000 New Financing 05/02/13 Boston
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More 01/24/11 Boston
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
$20M Series A For Karyopharm to Fight Cancer 11/03/10 Boston
Karyopharm Therapeutics Garners $20,000,000 Series A Financing 11/03/10 Boston
Page 1 of 1